Genetic relatedness of levofloxacin-nonsusceptible Streptococcus pneumoniae isolates from North America

Journal of Clinical Microbiology

Volumn 41, Issue 6, 2003, Pages 2458-2464

  Johnson, Crystal N ^a   Benjamin Jr , William H ^a,b   Moser, Stephen A ^a,b   Hollingshead, Susan K ^a   Zheng, Xiaotian ^d   Crain, Marilyn J ^a,c   Nahm, Moon H ^a,b   Waites, Ken B ^a,b  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; LEVOFLOXACIN; MOXIFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CLONE; DNA SEQUENCE; GENE SEQUENCE; GENETIC VARIABILITY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; NONHUMAN; NORTH AMERICA; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SEQUENCE ANALYSIS; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; TECHNIQUE;

BACTERIA (MICROORGANISMS); POSIBACTERIA; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0038519565     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.6.2458-2464.2003     Document Type: Article

References (43)

1. Alou, L., M. Ramirez, C. Garcia-Rey, J. Prieto, and H. de Lencastre. 2001. Streptococcus pneumoniae isolates with reduced susceptibility to ciprofloxacin in Spain: clonal diversity and appearance of ciprofloxacin-resistant epidemic clones. Antimicrob. Agents Chemother. 45:2955-2957.
2. Appelbaum, P. C. 1992. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin. Infect. Dis 15:77-83.
3. Bast, D. J., D. E. Low, C. L. Duncan, L. Kilburn, L. A. Mandell, R, J. Davidson, and J. C. de Azavedo. 2000. Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae: contributions of type II topoisomerase mutations and efflux to levels of resistance. Antimicrob. Agents Chemother. 44:3049-3054.
4. Brueggemann, A. B., S. L. Coffman, P. Rhomberg, H. Huynh, L. Almer, A. Nilius, R. Flamm, and G. V. Doern. 2002. Fluoroquinolone resistance in Streptococcus pneumoniae in the United States since 1994-1995. Antimicrob. Agents Chemother. 46:680-688.
5. Chen, D. K., A. McGeer, J. C. de Azavedo, and D. E. Low. 1999. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. N. Engl. J. Med. 341:233-239.
6. Corso, A., E. P. Severina, V. F. Petruk, Y. R. Mauriz, and A. Tomasz. 1998. Molecular characterization of penicillin-resistant Streptococcus pneumoniae isolates causing respiratory disease in the United States. Microb. Drug Resist. 4:325-337.
7. Davidson, R., R. Cavalcanti, J. L. Brunton, D. J. Bast, J. C. de Azavedo, P. Kibsey, C. Fleming, and D. E. Low. 2002. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. N. Engl. J. Med. 346:747-750.
8. Doern, G. V., A. B. Brueggemann, M. Blocker, M. Dunne, H. P. Holley, Jr., K. S. Kehl, J. Duval, K. Kugler, S. Putnam, A. Rauch, and M. A. Pfaller. 1998. Clonal relationships among high-level penicillin-resistant Streptococcus pneumoniae in the United States. Clin. Infect. Dis. 27:757-761.
9. Doern, G. V., A. B. Brueggemann, H. Huynh, and E. Wingert. 1999. Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997-98. Emerg. Infect. Dis. 5:757-765.
10. Doern, G. V., K. P. Heilmann, H. K. Huynh, P. R. Rhomberg, S. L. Coffman, and A. B. Brueggemann. 2001. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995. Antimicrob. Agents Chemother. 45:1721-1729.
11. Doern, G. V., M. A. Pfaller, M. E. Erwin, A. B. Brueggemann, and R. N. Jones. 1998. The prevalence of fluoroquinolone resistance among clinically significant respiratory tract isolates of Streptococcus pneumoniae in the United States and Canada-1997 results from the SENTRY Antimicrobial Surveillance Program. Diagn Microbiol. Infect. Dis. 32:313-316.
12. Doit, C., B. Picard, C. Loukil, P. Geslin, and E. Bingen. 2000. Molecular epidemiology survey of penicillin-susceptible and -resistant Streptococcus pneumoniae recovered from patients with meningitis in France. J. Infect. Dis. 181:1971-1978.
13. Dunne, W. M., Jr., K. S. Kehl, C. A. Holland-Staley, A. B. Brueggemann, M. A. Pfaller, and G. V. Doern. 2001. Comparison of results generated by serotyping, pulsed-field restriction analysis, ribotyping, and repetitive-sequence PCR used to characterize penicillin-resistant pneumococci from the United States. J. Clin. Microbiol, 39:1791-1795.
14. Enright, M. C., and B. G. Spratt. 1998. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 144:3049-3060.
15. Fenoll, A., I. Jado, D. Vicioso, A. Perez, and J. Casal. 1998. Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: update (1990 to 1996). J. Clin. Microbiol. 36:3447-3454.
16. Fukuda, H., and K. Hiramatsu. 1999. Primary targets of fluoroquinolones in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 43:410-412.
17. Gherardi, G., J. S. Inostrozo, M. O'Ryan, V. Prado, S. Prieto, C. Arellano, R. R. Facklam, and B. Beall. 1999. Genotypic survey of recent beta-lactam-resistant pneumococcal nasopharyngeal isolates from asymptomatic children in Chile. J. Clin. Microbiol. 37:3725-3730.
18. Gill, M. J., N. P. Brenwald, and R. Wise. 1999. Identification of an efflux pump gene, pmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 43:187-189.
19. Ho, P. L., T. L. Que, D. N. Tsang, T. K. Ng, K. H. Chow, and W. H. Seto, 1999. Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong. Antimicrob. Agents Chemother. 43:1310-1313.
20. Ho, P. L., R. W. Yung, D. N. Tsang, T. L. Que, M. Ho, W. H. Seto, T. K. Ng, W. C. Yam, and W. W. Ng. 2001. Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000. J. Antimicrob. Chemother. 48:659-665.
21. Johnson, C. N., W. H. Benjamin, Jr., B. M. Gray, M. C. Crain, K. M. Edwards, and K. B. Waites. 2001. In vitro activity, of ABT-773, telithromycin and eight other antimicrobials against erythromycin-resistant Streptococcus pneumoniae respiratory isolates of children. Int. J. Antimicrob. Agents 18: 531-535.
22. Jones, M. E., D. F. Sahm, N. Martin, S. Scheuring, P. Heisig, C. Thornsberry, K. Kohrer, and F. J. Schmitz. 2000. Prevalence of gyrA, gyrB, parC, and pare mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from Worldwide Surveillance Studies during the 1997-1998 respiratory season. Antimicrob. Agents Chemother. 44:462-466.
23. Jones, R. N., and M. A. Pfaller. 2000. Macrolide and fluoroquinolone (levofloxacin) resistances among Streptococcus pneumoniae strains: significant trends from the SENTRY Antimicrobial Surveillance Program (North America, 1997-1999). J. Clin. Microbiol. 38:4298-4299.
24. Kays, M. B., and G. A. Denys. 2001. Fluoroquinolone susceptibility, resistance, and pharmacodynamics versus clinical isolates of Streptococcus pneumoniae from Indiana. Diagn. Microbiol. Infect. Dis. 40:193-198.
25. Klugman, K. P. 1990. Pneumococcal resistance to antibiotics. Clin. Microbiol. Rev. 3:171-196.
26. Klugman, K. P., and H. J. Koornhof. 1988. Drug resistance patterns and serogroups or serotypes of pneumococcal isolates from cerebrospinal fluid or blood, 1979-1986. J. Infect. Dis. 158:956-964.
27. Koeuth, T., J. Versalovic, and J. R. Lupski. 1995. Differential subsequence conservation of interspersed repetitive Streptococcus pneumoniae BOX elements in diverse bacteria. Genome Res. 5:408-418.
28. Louie, M., L. Louie, G. Papia, J. Talbot, M. Lovgren, and A. E. Simor. 1999. Molecular analysis of the genetic variation among penicillin-susceptible and penicillin-resistant Streptococcas pneamoniae serotypes in Canada. J. Infect. Dis. 179:892-900.
29. Luna, V. A., and M. C. Roberts. 1999. In-vitro activities of 11 antibiotics against 75 strains of Streptococcus pneumoniae with reduced susceptibilities to penicillin isolated from patients in Washington state. J. Antimicrob. Chemother. 44:578-580.
30. Marians, K. J., and H. Hiasa. 1997. Mechanism of quinolone action. A drug-induced structural perturbation of the DNA precedes strand cleavage by topoisomerase IV. J. Biol. Chem. 272:9401-9409.
31. McDougal, L. K., J. K. Rasheed, J. W. Biddle, and F. C. Tenover. 1995. Identification of multiple clones of extended-spectrum cephalosporin-resistant Streptococcus pneumoniae isolates in the United States. Antimicrob. Agents Chemother. 39:2282-2288.
32. McEllistrem, M. C., M. Pass, J. A. Elliott, C. G. Whitney, and L. H. Harrison. 2000. Clonal groups of penicillin-nonsusceptible Streptococcus pneumoniae in Baltimore, Maryland: a population-based, molecular epidemiologic study. J. Clin. Microbiol. 38:4367-4372.
33. McGee, L., C. E. Goldsmith, and K. P. Klugman. 2002. Fluoroquinolone resistance among clinical isolates of Streptococcus pneumoniae belonging to international multiresistant clones. J. Antimicrob. Chemother. 49:173-176.
34. McGee, L., L. McDougal, J. Zhou, B. G. Spratt, F. C. Tenover, R. George, R. Hakenbeck, W. Hryniewicz, J. C. Lefevre, A. Tomasz, and K. P. Klugman. 2001. Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network. J. Clin. Microbiol. 39:2565-2571.
35. McGee, L., H. Wang, A. Wasas, R. Huebner, M. Chen, and K. P. Klugman. 2001. Prevalence of serotypes and molecular epidemiology of Streptococcus pneumoniae strains isolated from children in Beijing, China: identification of two novel multiply-resistant clones. Microb. Drug Resist. 7:55-63.
36. Nichol, K. A., G. G. Zhanel, and D. J. Hoban. 2003. Molecular epidemiology of penicillin-resistant and ciprofloxacin-resistant Streptococcus pneumoniae in Canada. Antimicrob. Agents Chemother. 47:804-808.
37. Pan, X. S., J. Ambler, S. Mehtar, and L. M. Fisher. 1996. Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae. Amimicrob. Agents Chemother. 40:2321-2326.
38. Pan, X. S., and L. M. Fisher. 1996. Cloning and characterization of the parC and pare genes of Streptococcus pneumoniae encoding DNA topoisomerase IV: role in fluoroquinolone resistance. J. Bacteriol. 178:4060-4069.
39. Richter, S. S., K. P. Heilmann, S. L. Coffman, H. K. Huynb, A. B. Brueggemann, M. A. Pfaller, and G. V. Doern. 2002. The molecular epidemiology of penicillin-resistant Streptococcus pneumoniae in the United States, 1994-2000. Clin. Infect. Dis. 34:330-339.
40. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminatham. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
41. Weigel, L. M., G. J. Anderson, R. R. Facklam, and F. C. Tenover. 2001. Genetic analyses of mutations contributing to fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 45:3517-3523.
42. Zhanel, G. G., A. Walkty, K. Nichol, H. Smith, A. Noreddin, and D. J. Hoban. 2003. Molecular characterization of fluoroquinolone resistant Streptococcus pneumoniae clinical isolates obtained from across Canada. Diagn. Microbiol. Infect. Dis. 45:63-67.
43. Zheng, X., C. Johnson, Y. Lu, R. Yanagihara, S. Hollingshead, M. Crain, W. Benjamin, Jr., and K. B. Waites. 2001. Clinical isolates of Streptococcus pneumoniae resistant to levofloxacin contain mutations in both gyrA and parC genes. Int. J. Antimicrob. Agents 18:373-378.